Arbutus Biopharma Corporation
ABUS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$8 | $3 | -$25 | -$13 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $1 | $1 | $4 | $2 |
| Change in WC | $1 | -$18 | $5 | -$0 |
| Other Non-Cash | -$0 | -$1 | $2 | $0 |
| Operating Cash Flow | -$6 | -$16 | -$13 | -$10 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$51 | -$28 | -$35 | -$43 |
| Inv. Sales/Matur. | $41 | $44 | $46 | $57 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$10 | $16 | $11 | $13 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | -$0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $1 | $0 | $3 | $1 |
| Financing Cash Flow | $1 | $0 | $3 | $1 |
| Forex Effect | -$0 | $0 | $0 | -$0 |
| Net Chg. in Cash | -$15 | $0 | $1 | $4 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $37 | $37 | $36 | $32 |
| End Cash | $22 | $37 | $37 | $36 |
| Free Cash Flow | -$6 | -$16 | -$13 | -$10 |